Metformin (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metformin" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

12nih.gov

4^th place

8^th place

10doi.org

2^nd place

5^th place

4web.archive.org

1^st place

2^nd place

3books.google.com

3^rd place

11^th place

2drugs.com

399^th place

169^th place

2archive.org

6^th place

9^th place

1cbz.si

low place

607^th place

1termania.net

low place

34^th place

1chemsrc.com

low place

1endodiab.si

low place

1handle.net

102^nd place

416^th place

archive.org

Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (december 1978). »Disposition of metformin (N,N-dimethylbiguanide) in man«. Clinical Pharmacology and Therapeutics. 24 (6): 683–693. doi:10.1002/cpt1978246683. PMID 710026.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Lipska KJ, Bailey CJ, Inzucchi SE (Junij 2011). »Use of metformin in the setting of mild-to-moderate renal insufficiency«. Diabetes Care. 34 (6): 1431–1437. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.

books.google.com

Clinical Obesity (2. izd.). Oxford: John Wiley & Sons. 2008. str. 262. ISBN 978-0-470-98708-7. Arhivirano iz spletišča dne 8. septembra 2017.
Fischer, Janos (2010). Analogue-based Drug Discovery II. John Wiley & Sons. str. 49. ISBN 978-3-527-63212-1. Arhivirano iz spletišča dne 8. septembra 2017.
McKee, Mitchell Bebel Stargrove, Jonathan Treasure, Dwight L. (2008). Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies. St. Louis, Mo.: Mosby/Elsevier. str. 217. ISBN 978-0-323-02964-3. Arhivirano iz spletišča dne 8. septembra 2017.

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BSEZNAMUCINKNAZIV%5D=_metformin*)&SearchOrder=4&SearchMax=301 Centralna baza zdravil, vpogled: 31. 3. 2020.

chemsrc.com

»metformin_msds«.

doi.org

Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (december 1978). »Disposition of metformin (N,N-dimethylbiguanide) in man«. Clinical Pharmacology and Therapeutics. 24 (6): 683–693. doi:10.1002/cpt1978246683. PMID 710026.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Dunn CJ, Peters DH (Maj 1995). »Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus«. Drugs. 49 (5): 721–49. doi:10.2165/00003495-199549050-00007. PMID 7601013.
Hundal RS, Inzucchi SE (2003). »Metformin: new understandings, new uses«. Drugs. 63 (18): 1879–1894. doi:10.2165/00003495-200363180-00001. PMID 12930161.
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S (Junij 2016). »Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis«. Annals of Internal Medicine. 164 (11): 740–751. doi:10.7326/M15-2650. PMID 27088241.
Triggle CR, Ding H (Januar 2017). »Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium«. Acta Physiologica. 219 (1): 138–151. doi:10.1111/apha.12644. PMID 26680745.
Lipska KJ, Bailey CJ, Inzucchi SE (Junij 2011). »Use of metformin in the setting of mild-to-moderate renal insufficiency«. Diabetes Care. 34 (6): 1431–1437. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.
Lautatzis ME, Goulis DG, Vrontakis M (november 2013). »Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review«. Metabolism. 62 (11): 1522–1534. doi:10.1016/j.metabol.2013.06.006. PMID 23886298.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR (Maj 2010). »The use of metformin in type 1 diabetes: a systematic review of efficacy«. Diabetologia. 53 (5): 809–820. doi:10.1007/s00125-009-1636-9. PMID 20057994.
Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL (september 2007). »Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus«. Annals of Internal Medicine. 147 (6): 386–399. doi:10.7326/0003-4819-147-6-200709180-00178. PMID 17638715.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Khurana R, Malik IS (Januar 2010). »Metformin: safety in cardiac patients«. Heart. 96 (2): 99–102. doi:10.1136/hrt.2009.173773. PMID 19564648.

drugs.com

»Metformin Use During Pregnancy«. Drugs.com. 10. september 2019. Pridobljeno 4. februarja 2020.
»Metformin Hydrochloride«. The American Society of Health-System Pharmacists. Arhivirano iz spletišča dne 24. decembra 2016. Pridobljeno 2. januarja 2017.

endodiab.si

https://endodiab.si/priporocila/smernice-za-vodenje-sladkorne-bolezni/ Slovenske smernice za klinično obravnavo sladkorne bolezni tipa 2, leto 2016, vpogled: 31. 3. 2020.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (december 1978). »Disposition of metformin (N,N-dimethylbiguanide) in man«. Clinical Pharmacology and Therapeutics. 24 (6): 683–693. doi:10.1002/cpt1978246683. PMID 710026.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Dunn CJ, Peters DH (Maj 1995). »Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus«. Drugs. 49 (5): 721–49. doi:10.2165/00003495-199549050-00007. PMID 7601013.
Hundal RS, Inzucchi SE (2003). »Metformin: new understandings, new uses«. Drugs. 63 (18): 1879–1894. doi:10.2165/00003495-200363180-00001. PMID 12930161.
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S (Junij 2016). »Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis«. Annals of Internal Medicine. 164 (11): 740–751. doi:10.7326/M15-2650. PMID 27088241.
»Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects«. Prescrire International. 23 (154): 269–272. november 2014. PMID 25954799.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Triggle CR, Ding H (Januar 2017). »Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium«. Acta Physiologica. 219 (1): 138–151. doi:10.1111/apha.12644. PMID 26680745.
Lipska KJ, Bailey CJ, Inzucchi SE (Junij 2011). »Use of metformin in the setting of mild-to-moderate renal insufficiency«. Diabetes Care. 34 (6): 1431–1437. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.
Lautatzis ME, Goulis DG, Vrontakis M (november 2013). »Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review«. Metabolism. 62 (11): 1522–1534. doi:10.1016/j.metabol.2013.06.006. PMID 23886298.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR (Maj 2010). »The use of metformin in type 1 diabetes: a systematic review of efficacy«. Diabetologia. 53 (5): 809–820. doi:10.1007/s00125-009-1636-9. PMID 20057994.
Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL (september 2007). »Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus«. Annals of Internal Medicine. 147 (6): 386–399. doi:10.7326/0003-4819-147-6-200709180-00178. PMID 17638715.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Khurana R, Malik IS (Januar 2010). »Metformin: safety in cardiac patients«. Heart. 96 (2): 99–102. doi:10.1136/hrt.2009.173773. PMID 19564648.

ncbi.nlm.nih.gov

Lipska KJ, Bailey CJ, Inzucchi SE (Junij 2011). »Use of metformin in the setting of mild-to-moderate renal insufficiency«. Diabetes Care. 34 (6): 1431–1437. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5526683/metformin?query=metformin&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 31. 3. 2020.

web.archive.org

»Metformin Hydrochloride«. The American Society of Health-System Pharmacists. Arhivirano iz spletišča dne 24. decembra 2016. Pridobljeno 2. januarja 2017.
Clinical Obesity (2. izd.). Oxford: John Wiley & Sons. 2008. str. 262. ISBN 978-0-470-98708-7. Arhivirano iz spletišča dne 8. septembra 2017.
Fischer, Janos (2010). Analogue-based Drug Discovery II. John Wiley & Sons. str. 49. ISBN 978-3-527-63212-1. Arhivirano iz spletišča dne 8. septembra 2017.
McKee, Mitchell Bebel Stargrove, Jonathan Treasure, Dwight L. (2008). Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies. St. Louis, Mo.: Mosby/Elsevier. str. 217. ISBN 978-0-323-02964-3. Arhivirano iz spletišča dne 8. septembra 2017.